Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 597 posts found.

coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

April 22, 2020
Research and Development COVID-19, coronavirus, hydroxychloroquine

Hydroxychloroquine has faced setbacks as a potential COVID-19 treatment, as it failed a clinical trial in France and a study …

News
testing_kit

First in-home COVID-19 testing kit approved by the FDA

April 22, 2020
Research and Development COVID-19, Testing kits, coronavirus, testing swabs

The US Food and Drug Administration have granted emergency clearance to the first in-home COVID-19 testing kit. The nasal swab …

News
stock_drugs

National Institutes of Health says COVID-19 patients should not take hydroxychloroquine

April 22, 2020
Research and Development COVID-19, coronavirus, hydroxychloroquine

Experts at the US National Institutes of Health (NIH) have drafted treatment guidelines for the use of hydroxychloroquine in COVID-19 …

News
british-ambulance-1433888698aq4

Deaths in England and Wales hit 20 year high due to COVID-19 fatalities

April 21, 2020
Manufacturing and Production COVID-19, COVID-19 UK, coronavirus, coronavirus uk

Deaths in England and Wales have hit a 20 year high, boosted by fatalities from the COVID-19 coronavirus. The Office …

News
fda

FDA to take steps to ease shortages of drugs for COVID-19 patients on ventilators

April 21, 2020
Manufacturing and Production COVID-19, Ventilators, coronavirus

The FDA is to allow small compound pharmacies to fill the shortages of medicines needed for patients with COVID-19 who …

News
800px-rhesus_macaque_macaca_mulatta_in_kinnarsani_ws_ap_w_img_5792

Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial

April 20, 2020
Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir

A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …

News
covid-19_testing

English COVID-19 cases to be tracked by ethnicity

April 20, 2020
Sales and Marketing African-Americans, BAME, COVID-19, coronavirus

Cases of coronavirus are set to be tracked by ethnicity in England following an announced government review. The governments have …

News
pillsss

Hydroxychloroquine fails COVID-19 clinical trial in France

April 20, 2020
Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine

The malaria treatment hydroxychloroquine is facing further scrutiny as a coronavirus treatment after failed trials in France. The most recent …

News
fda

FDA cautions that drug reviews will be slower due to COVID-19

April 17, 2020
Medical Communications COVID-19, FDA, coronavirus

The FDA has warned that they may not be able to sustain its current levels of timely reviews and approvals …

News
moderna-605x340

US Government’s BARDA to fund Moderna’s coronavirus vaccine by $483m

April 17, 2020
Medical Communications, Research and Development BARDA, COVID-19, Moderna, coronavirus, pharma

Moderna has secured $483 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), to drive development and …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …

News

Leaked data show Gilead’s remdesivir allows severe COVID-19 patients to be discharged after six days

April 17, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …

News
poshoo

New Chinese study shows Hydroxychloroquine does not speed up COVID-19 recovery

April 16, 2020
Business Services COVID-19, chloroquine, coronavirus, hydroxychloroquine

The anti-malaria drug hydroxychloroquine does not speed up recovery from COVID-19, according to a new Chinese study. The study was …

News
gilead-sciences

Gilead halts COVID-19 remdesivir trial due to enrolment issues, efficacy of the drug uncertain

April 16, 2020
Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

A clinical trial in China investigating Gilead’s antiviral therapy remdesivir as a potential treatment for COVID-19 has been placed on …

News
social_distancing

Intermittent social distancing could last until 2022, according to a new study

April 16, 2020
Business Services COVID, COVID-19, coronavirus, social distancing

Social distancing that has been put in place to stem the spread of COVID-19 coronavirus could be implemented up until …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024